Comparison of the test characteristics of procalcitonin to C-reactive protein and leukocytosis for the detection of serious bacterial infections in children presenting with fever without source: a systematic review and meta-analysis.

[1]  A. Gervaix,et al.  Identifying severe bacterial infection in children with fever without source , 2010, Expert review of anti-infective therapy.

[2]  J. Casado‐flores,et al.  Distinguishing between bacterial and aseptic meningitis in children: European comparison of two clinical decision rules , 2010, Archives of Disease in Childhood.

[3]  S. Manzano,et al.  Impact of procalcitonin on the management of children aged 1 to 36 months presenting with fever without source: a randomized controlled trial. , 2010, The American journal of emergency medicine.

[4]  A. Gervaix,et al.  Validation of a laboratory risk index score for the identification of severe bacterial infection in children with fever without source , 2010, Archives of Disease in Childhood.

[5]  P. Schuetz,et al.  Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[6]  A. Gervaix,et al.  Comparison of procalcitonin measurement by a semi-quantitative method and an ultra-sensitive quantitative method in a pediatric emergency department. , 2009, Clinical biochemistry.

[7]  R. Jhaveri,et al.  Fever without localizing signs in children: a review in the post-Hib and postpneumococcal era. , 2009, Minerva pediatrica.

[8]  A. Kopitar,et al.  Neutrophil and monocyte CD64 indexes, lipopolysaccharide-binding protein, procalcitonin and C-reactive protein in sepsis of critically ill neonates and children , 2009, Intensive Care Medicine.

[9]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement , 2009, BMJ : British Medical Journal.

[10]  D. Moher,et al.  Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement , 2009, BMJ : British Medical Journal.

[11]  J. Emparanza,et al.  Markers that predict serious bacterial infection in infants under 3 months of age presenting with fever of unknown origin , 2009, Archives of Disease in Childhood.

[12]  J. Casado‐flores,et al.  Serum procalcitonin level and other biological markers to distinguish between bacterial and aseptic meningitis in children: a European multicenter case cohort study. , 2008, Archives of pediatrics & adolescent medicine.

[13]  A. Yinnon,et al.  Neutrophil CD64 Expression as a Diagnostic Marker of Bacterial Infection in Febrile Children Presenting to a Hospital Emergency Department , 2008, Pediatric emergency care.

[14]  Andrew Dauber,et al.  Procalcitonin in Young Febrile Infants for the Detection of Serious Bacterial Infections , 2008, Pediatrics.

[15]  L. Baraff.  Management of infants and young children with fever without source. , 2008, Pediatric annals.

[16]  C. Padovani,et al.  Interleukin-6 and procalcitonin in children with sepsis and septic shock. , 2008, Cytokine.

[17]  A. Gervaix,et al.  The Search for Adenovirus 14 in Children in Houston, Texas , 2008, The Pediatric infectious disease journal.

[18]  J. Lacroix,et al.  Procalcitonin and C-reactive protein as markers of bacterial infection in critically ill children at onset of systemic inflammatory response syndrome* , 2008, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[19]  F. Valent,et al.  The value of clinical features in differentiating between viral, pneumococcal and atypical bacterial pneumonia in children , 2008, Acta paediatrica.

[20]  É. Bingen,et al.  Marqueurs de l'inflammation et infection ostéoarticulaire , 2007 .

[21]  M. Plebani,et al.  Procalcitonin and C-Reactive Protein as Diagnostic Markers of Severe Bacterial Infections in Febrile Infants and Children in the Emergency Department , 2007, The Pediatric infectious disease journal.

[22]  D. Gendrel,et al.  [Distinction between bacterial and aseptic meningitis in children: refinement of a clinical decision rule]. , 2007, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[23]  M. Chalumeau,et al.  Distinction entre les méningites bactériennes et virales chez l'enfant : affinement d'une règle de décision clinique ☆ , 2007 .

[24]  S. Hojker,et al.  Lipopolysaccharide-binding protein, lipopolysaccharide, and soluble CD14 in sepsis of critically ill neonates and children , 2007, Intensive Care Medicine.

[25]  D. Herd.  In children under age three does procalcitonin help exclude serious bacterial infection in fever without focus? , 2007, Archives of Disease in Childhood.

[26]  J. Rozé,et al.  Contribution of procalcitonin to occult bacteraemia detection in children , 2007, Scandinavian journal of infectious diseases.

[27]  D. Grobbee,et al.  Validating and updating a prediction rule for serious bacterial infection in patients with fever without source , 2007, Acta paediatrica.

[28]  I. Kassis,et al.  Values of C‐reactive protein, procalcitonin, and Staphylococcus‐specific PCR in neonatal late‐onset sepsis , 2006, Acta paediatrica.

[29]  Charles G Macias,et al.  Prospective Evaluation of the Risk of Serious Bacterial Infection in Children Who Present to the Emergency Department With Hyperpyrexia (Temperature of 106°F or Higher) , 2006, Pediatrics.

[30]  P. Lebon,et al.  Serum procalcitonin and other biologic markers to distinguish between bacterial and aseptic meningitis. , 2006, The Journal of pediatrics.

[31]  M. Baker,et al.  Incidence and Predictors of Serious Bacterial Infections Among 57- to 180-Day-Old Infants , 2006, Pediatrics.

[32]  N. Rončević,et al.  [Fever without a focus in children 0-36 months of age]. , 2006, Medicinski pregled.

[33]  M. Hemels,et al.  Inflammatory Mediators for the Diagnosis and Treatment of Sepsis in Early Infancy , 2006, Pediatric Research.

[34]  W. Xu,et al.  [Serum procalcitonin levels in children with bacterial or viral meningitis]. , 2006, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics.

[35]  G. Garra,et al.  Reappraisal of criteria used to predict serious bacterial illness in febrile infants less than 8 weeks of age. , 2005, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[36]  M. Shenoy,et al.  Is procalcitonin useful in early diagnosis of serious bacterial infections in children? , 2005, Acta paediatrica.

[37]  M. Baker,et al.  Fever in the new millennium: a review of recent studies of markers of serious bacterial infection in febrile children , 2005, Current opinion in pediatrics.

[38]  A. V. van Rossum,et al.  Procalcitonin as an early marker of infection in neonates and children. , 2004, The Lancet. Infectious diseases.

[39]  M. Korppi.  Non‐specific host response markers in the differentiation between pneumococcal and viral pneumonia: What is the most accurate combination? , 2004, Pediatrics international : official journal of the Japan Pediatric Society.

[40]  S. Hojker,et al.  Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein , 2004, Intensive Care Medicine.

[41]  A. Kourtis,et al.  Practice Guidelines for the Management of Febrile Infants Less Than 90 Days of Age at the Ambulatory Network of a Large Pediatric Health Care System in the United States: Summary of New Evidence , 2004, Clinical pediatrics.

[42]  A. Gervaix,et al.  Bedside procalcitonin and C-reactive protein tests in children with fever without localizing signs of infection seen in a referral center. , 2003, Pediatrics.

[43]  C. Cubells,et al.  Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker , 2003 .

[44]  D. Isaacman,et al.  Utility of the serum C-reactive protein for detection of occult bacterial infection in children. , 2002, Archives of pediatrics & adolescent medicine.

[45]  M. Attia,et al.  C-reactive protein in febrile children 1 to 36 months of age with clinically undetectable serious bacterial infection. , 2001, Pediatrics.

[46]  D. Walshaw,et al.  The causes of fever in children attending hospital in the north of England. , 2001, The Journal of infection.

[47]  S. Suter,et al.  Procalcitonin, IL-6, IL-8, IL-1 receptor antagonist and C-reactive protein as identificators of serious bacterial infections in children with fever without localising signs , 2001, European Journal of Pediatrics.

[48]  L. Baraff.  Management of fever without source in infants and children. , 2000, Annals of emergency medicine.

[49]  R. Bolte,et al.  Applying Outpatient Protocols in Febrile Infants 1-28 Days of Age: Can the Threshold Be Lowered? , 2000, Clinical pediatrics.

[50]  J. Olshaker,et al.  The C-reactive protein. , 1999, The Journal of emergency medicine.

[51]  Gerta Rucker,et al.  Bmc Medical Research Methodology Open Access the Relationship between Quality of Research and Citation Frequency , 2022 .

[52]  T. Laskowska-Klita,et al.  [Concentration of C-reactive protein, procalcitonin and alpha-1-antitrypsin in blood of neonates and infants with signs of inflammation]. , 2002, Medycyna wieku rozwojowego.